Hippocampal biochemical, histological alterations, and pain modulation induced by zinc oxide nanoparticles: a review from animal studies
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Anesthesia and Neurotoxicity Research · Curcumin's Biomedical Applications · Neuroscience and Neuropharmacology Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (95)
Show source-provided references
1. Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S et al (2020) The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain 161(9):1976–198210.1097/j.pain.0000000000001939 ↗
2. Olesen AE, Andresen T, Staahl C, Drewes AM (2012) Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs. Pharmacol Rev 64(3):722–77910.1124/pr.111.005447 ↗
3. Negus SS, Vanderah TW, Brandt MR, Bilsky EJ, Becerra L, Borsook D (2006) Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J Pharmacol Exp Ther 319(2):507–51410.1124/jpet.106.106377 ↗
4. Bhansali D, Teng SL, Lee CS, Schmidt BL, Bunnett NW, Leong KW (2021) Nanotechnology for pain management: current and future therapeutic interventions. Nano Today 39:10122310.1016/j.nantod.2021.101223 ↗
5. Lima CKF, Sisnande T, Silva RVD, Silva V, Amaral JJD, Ochs SM et al (2023) Zinc deficiency disrupts pain signaling promoting nociceptive but not inflammatory pain in mice. An Acad Bras Cienc 95(suppl 1):e2022091410.1590/0001-3765202320220914 ↗
6. Liu T, Walker JS, Tracey DJ (1999) Zinc alleviates thermal hyperalgesia due to partial nerve injury. NeuroReport 10(3):645–64910.1097/00001756-199902250-00037 ↗
7. Larson AA, Kitto KF (1997) Manipulations of zinc in the spinal cord, by intrathecal injection of zinc chloride, disodium-calcium-EDTA, or dipicolinic acid, alter nociceptive activity in mice. J Pharmacol Exp Ther 282(3):1319–132510.1016/S0022-3565(24)36911-3 ↗
8. Matsunami M, Kirishi S, Okui T, Kawabata A (2011) Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels. Neuroscience 181:257–26410.1016/j.neuroscience.2011.02.044 ↗
9. Nozaki C, Vergnano AM, Filliol D, Ouagazzal AM, Le Goff A, Carvalho S et al (2011) Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit. Nat Neurosci 14(8):1017–102210.1038/nn.2844 ↗
10. Babaie S, Taghvimi A, Hong JH, Hamishehkar H, An S, Kim KH (2022) Recent advances in pain management based on nanoparticle technologies. J Nanobiotechnol 20(1):29010.1186/s12951-022-01473-y ↗
11. Takeda A, Minami A, Seki Y, Oku N (2004) Differential effects of zinc on glutamatergic and GABAergic neurotransmitter systems in the hippocampus. J Neurosci Res 75(2):225–22910.1002/jnr.10846 ↗
12. Torabi M, Kesmati M, Galehdari H, Varzi HN, Pourreza N (2020) MgO and ZnO nanoparticles anti-nociceptive effect modulated by glutamate level and NMDA receptor expression in the hippocampus of stressed and non-stressed rats. Physiol Behav 214:11272710.1016/j.physbeh.2019.112727 ↗
13. Torabi M. KM, Galehdari H (2024) Comparison the effect of nanoparticles of ZnO and MgO on GABAA receptor expression in the hippocampus of male rat in the presence and absence of acute stress. 23rd National and 11th International Iranian Biology Congress; Iran
14. Kesmati M, Torabi M (2014) Interaction between analgesic effect of nano and conventional size of zinc oxide and opioidergic system activity in animal model of acute pain. Basic Clin Neurosci 5(1):80–87
15. Agarwal H, Shanmugam V (2020) A review on anti-inflammatory activity of green synthesized zinc oxide nanoparticle: mechanism-based approach. Bioorg Chem 94:10342310.1016/j.bioorg.2019.103423 ↗
16. Leeyaphan C, Punnakitikashem P, Suiwongsa B, Komesmuneeborirak P, Chongtrakool P, Kulthanachairojana N et al (2025) Efficacy, safety, and cost-effectiveness of zinc oxide nanoparticles in Whitfield’s spirit solution for treating superficial fungal foot infections: a randomized controlled trial. Dermatol Ther (Heidelb) 15(2):351–36510.1007/s13555-025-01340-2 ↗
17. Cho WS, Kang BC, Lee JK, Jeong J, Che JH, Seok SH (2013) Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol 10:910.1186/1743-8977-10-9 ↗
18. Liu H, Yang H, Fang Y, Li K, Tian L, Liu X et al (2020) Neurotoxicity and biomarkers of zinc oxide nanoparticles in main functional brain regions and dopaminergic neurons. Sci Total Environ 705:13580910.1016/j.scitotenv.2019.135809 ↗
19. Nandhini J, Karthikeyan E, Rajeshkumar S (2024) Green synthesis of zinc oxide nanoparticles: eco-friendly advancements for biomedical marvels. Resour Chem Mater 3(4):294–316
20. Erfani Majd N, Tabandeh MR, Hosseinifar S, Rahimi Zarneh S (2021) Chemical and green ZnO nanoparticles ameliorated adverse effects of cisplatin on histological structure, antioxidant defense system and neurotrophins expression in rat hippocampus. J Chem Neuroanat 116:10199010.1016/j.jchemneu.2021.101990 ↗
21. Xie Y, Wang Y, Zhang T, Ren G, Yang Z (2012) Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors. J Biomed Sci 19(1):1410.1186/1423-0127-19-14 ↗
22. Lekki-Porębski SA, Rakowski M (1867) Grzelak A (2023) Free zinc ions, as a major factor of ZnONP toxicity, disrupts free radical homeostasis in CCRF-CEM cells. Biochim Biophys Acta Gen Subj 10:130447
23. Sudhakaran S, Ss A, Suresh Babu SVH, Pv M (2020) Determination of the bioavailability of zinc oxide nanoparticles using ICP-AES and associated toxicity. Colloids Surf B Biointerfaces 188:11076710.1016/j.colsurfb.2019.110767 ↗
24. Baek M, Chung HE, Yu J, Lee JA, Kim TH, Oh JM et al (2012) Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int J Nanomedicine 7:3081–3097
25. Choi SJ, Choy JH (2014) Biokinetics of zinc oxide nanoparticles: toxicokinetics, biological fates, and protein interaction. Int J Nanomedicine 9(Suppl 2):261–9
26. Saptarshi SR, Duschl A, Lopata AL (2013) Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnology 11:2610.1186/1477-3155-11-26 ↗
27. Sabella S, Carney RP, Brunetti V, Malvindi MA, Al-Juffali N, Vecchio G et al (2014) A general mechanism for intracellular toxicity of metal-containing nanoparticles. Nanoscale 6(12):7052–706110.1039/c4nr01234h ↗
28. Wang L, Wang L, Ding W, Zhang F (2010) Acute toxicity of ferric oxide and zinc oxide nanoparticles in rats. J Nanosci Nanotechnol 10(12):8617–862410.1166/jnn.2010.2483 ↗
29. Li CH, Shen CC, Cheng YW, Huang SH, Wu CC, Kao CC et al (2012) Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology 6(7):746–75610.3109/17435390.2011.620717 ↗
30. Chen B, Yu P, Chan WN, Xie F, Zhang Y, Liang L et al (2024) Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets. Sig Transduct Target Ther 9(1):610.1038/s41392-023-01679-y ↗
31. Liao C, Jin Y, Li Y, Tjong SC (2020) Interactions of zinc oxide nanostructures with mammalian cells: cytotoxicity and photocatalytic toxicity. Int J Mol Sci 21(17):630510.3390/ijms21176305 ↗
32. Nilechi M, Eidi A, Galehdari H, Kesmati M (2021) Effects of zinc oxide nanoparticles on the expression of zinc transporter 1–4 genes in the hippocampus of male rats under acute stress. Kafkas Üniv Vet Fak Derg 27(2):235–242
33. Jafar Sameri M, Savari F, Mard SA, Rezaie A, Kalantar M (2024) Zinc oxide nanoparticles ameliorate histological alterations through apoptotic gene regulation in rat model of liver ischemia-reperfusion injury. Rep Biochem Mol Biol 12(4):619–630
34. Watson CY, Molina RM, Louzada A, Murdaugh KM, Donaghey TC, Brain JD (2015) Effects of zinc oxide nanoparticles on Kupffer cell phagosomal motility, bacterial clearance, and liver function. Int J Nanomedicine 10:4173–418410.2147/IJN.S82807 ↗
35. Deen WM, Lazzara MJ, Myers BD (2001) Structural determinants of glomerular permeability. Am J Physiol Renal Physiol 281(4):F579–F59610.1152/ajprenal.2001.281.4.F579 ↗
36. Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 3(5):703–71710.2217/17435889.3.5.703 ↗
37. Paek HJ, Lee YJ, Chung HE, Yoo NH, Lee JA, Kim MK et al (2013) Modulation of the pharmacokinetics of zinc oxide nanoparticles and their fates in vivo. Nanoscale 5(23):11416–1142710.1039/c3nr02140h ↗
38. Choi J, Kim H, Kim P, Jo E, Kim HM, Lee MY et al (2015) Toxicity of zinc oxide nanoparticles in rats treated by two different routes: single intravenous injection and single oral administration. J Toxicol Environ Health A 78(4):226–24310.1080/15287394.2014.949949 ↗
39. Shreiki H, Bashour G, Kinjo H (2025) Successful healing of chronic venous ulcer using zinc oxide nanoparticles and compression therapy in a 75-year-old Syrian female: a case report. Ann Med Surg (Lond) 87(1):417–42010.1097/MS9.0000000000002881 ↗
40. Youssef FS, Ismail SH, Fouad OA, Mohamed GG (2024) Green synthesis and biomedical applications of zinc oxide nanoparticles. Review. Egypt J Vet Sci 55(1):287–311
41. Ibne Shoukani H, Nisa S, Bibi Y, Zia M, Sajjad A, Ishfaq A et al (2024) Ciprofloxacin loaded PEG coated ZnO nanoparticles with enhanced antibacterial and wound healing effects. Sci Rep 14(1):468910.1038/s41598-024-55306-z ↗
42. Shrivastava R, Raza S, Yadav A, Kushwaha P, Flora SJ (2014) Effects of sub-acute exposure to TiO2, ZnO and Al2O3 nanoparticles on oxidative stress and histological changes in mouse liver and brain. Drug Chem Toxicol 37(3):336–34710.3109/01480545.2013.866134 ↗
43. Hamza RZ, Al-Salmi FA, El-Shenawy NS (2019) Evaluation of the effects of the green nanoparticles zinc oxide on monosodium glutamate-induced toxicity in the brain of rats. Peer J 7:e746010.7717/peerj.7460 ↗
44. Gantedi S, Anreddy RNR (2012) Toxicological studies of zinc oxide nanomaterials in rats. Toxicol Environ Chem 94(9):1768–177910.1080/02772248.2012.731290 ↗
45. Elshama SS, El-Kenawy AE-M, Osman H-EH (2017) Histopathological study of zinc oxide nanoparticle-induced neurotoxicity in rats. Toxicology 13:95–103
46. Bryant SL, Eixenberger JE, Rossland S, Apsley H, Hoffmann C, Shrestha N et al (2017) ZnO nanoparticles modulate the ionic transport and voltage regulation of lysenin nanochannels. J Nanobiotechnol 15(1):9010.1186/s12951-017-0327-9 ↗
47. Farokhcheh M, Hejazian L, Akbarnejad Z, Pourabdolhossein F, Hosseini SM, Mehraei TM et al (2021) Geraniol improved memory impairment and neurotoxicity induced by zinc oxide nanoparticles in male wistar rats through its antioxidant effect. Life Sci 282:11982310.1016/j.lfs.2021.119823 ↗
48. Pantic S, Skodric SR, Loncar Z, Pantic I (2019) Zinc oxide nanoparticles: potential novel applications in cellular physiology, pathology, neurosciences and cancer research. Rev Adv Mater Sci 58(1):17–2110.1515/rams-2019-0002 ↗
49. Tian L, Lin B, Wu L, Li K, Liu H, Yan J et al (2015) Neurotoxicity induced by zinc oxide nanoparticles: age-related differences and interaction. Sci Rep 5:1611710.1038/srep16117 ↗
50. Shim KH, Jeong KH, Bae SO, Kang MO, Maeng EH, Choi CS et al (2014) Assessment of ZnO and SiO2 nanoparticle permeability through and toxicity to the blood-brain barrier using Evans blue and TEM. Int J Nanomedicine 9(Suppl 2):225–33
51. Jiang J, Pi J, Cai J (2018) The Advancing of Zinc Oxide Nanoparticles for Biomedical Applications. Bioinorg Chem Appl 2018:106256210.1155/2018/1062562 ↗
52. Afifi M, Abdelazim AM (2015) Ameliorative effect of zinc oxide and silver nanoparticles on antioxidant system in the brain of diabetic rats. Asian Pac J Trop Biomed 5(10):874–87710.1016/j.apjtb.2015.06.010 ↗
53. Akintunde JK, Farai TI, Arogundade MR, Adeleke JT (2021) Biogenic zinc-oxide nanoparticles of Moringa oleifera leaves abrogates rotenone induced neuroendocrine toxicity by regulation of oxidative stress and acetylcholinesterase activity. Biochem Biophys Rep 26:100999
54. Goma AA, Salama AR, Tohamy HG, Rashed RR, Shukry M, El-Kazaz SE (2024) Examining the influence of zinc oxide nanoparticles and bulk zinc oxide on rat brain functions: a comprehensive neurobehavioral, antioxidant, gene expression, and histopathological investigation. Biol Trace Elem Res 202(10):4654–467310.1007/s12011-023-04043-x ↗
55. Deng X, Luan Q, Chen W, Wang Y, Wu M, Zhang H et al (2009) Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology 20(11):11510110.1088/0957-4484/20/11/115101 ↗
56. Valdiglesias V, Costa C, Kiliç G, Costa S, Pásaro E, Laffon B et al (2013) Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles. Environ Int 55:92–10010.1016/j.envint.2013.02.013 ↗
57. Madsen E, Gitlin JD (2007) Copper and iron disorders of the brain. Annu Rev Neurosci 30:317–33710.1146/annurev.neuro.30.051606.094232 ↗
58. Guo Z, Zhang P, Luo Y, Xie HQ, Chakraborty S, Monikh FA et al (2020) Intranasal exposure to ZnO nanoparticles induces alterations in cholinergic neurotransmission in rat brain. Nano Today 35:10097710.1016/j.nantod.2020.100977 ↗
59. Gu Z, Lamb PW, Yakel JL (2012) Cholinergic coordination of presynaptic and postsynaptic activity induces timing-dependent hippocampal synaptic plasticity. J Neurosci 32(36):12337–1234810.1523/JNEUROSCI.2129-12.2012 ↗
60. Murali M, Manjula S, Shilpa N, Ravishankar DK, Shivakumara CS, Thampy A et al (2022) Facile synthesis of ZnO-NPs from yellow creeping daisy (Sphagneticola trilobata L.) attenuates cell proliferation by inducing cellular level apoptosis against colon cancer. J King Saud Univ Sci 34(5):102084.10.1016/j.jksus.2022.102084 ↗
61. Dkhil MA, Diab MSM, Aljawdah HMA, Murshed M, Hafiz TA, Al-Quraishy S et al (2020) Neuro-biochemical changes induced by zinc oxide nanoparticles. Saudi J Biol Sci 27(10):2863–286710.1016/j.sjbs.2020.07.009 ↗
62. Kumar MV, Kumari BN, Yellamma K (2010) Zinc toxicity to aminergic neurotransmitters in rat brain. Toxicol Int 17(2):52–5810.4103/0971-6580.72670 ↗
63. Ryu HJ, Seo MY, Jung SK, Maeng EH, Lee SY, Jang DH et al (2014) Zinc oxide nanoparticles: a 90-day repeated-dose dermal toxicity study in rats. Int J Nanomedicine 9(Suppl 2):137–44
64. Sruthi S, Ashtami J, Mohanan PV (2018) Biomedical application and hidden toxicity of zinc oxide nanoparticles. Mater Today Chem 10:175–18610.1016/j.mtchem.2018.09.008 ↗
65. Doboszewska U, Wlaź P, Nowak G, Radziwoń-Zaleska M, Cui R, Młyniec K (2017) Zinc in the monoaminergic theory of depression: its relationship to neural plasticity. Neural Plast 2017:368275210.1155/2017/3682752 ↗
66. Paoletti P, Ascher P, Neyton J (1997) High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 17(15):5711–572510.1523/JNEUROSCI.17-15-05711.1997 ↗
67. Koh JY, Choi DW (1994) Zinc toxicity on cultured cortical neurons: involvement of N-methyl-D-aspartate receptors. Neuroscience 60(4):1049–105710.1016/0306-4522(94)90282-8 ↗
68. Rani V, Verma Y, Rana K, Rana SVS (2018) Zinc oxide nanoparticles inhibit dimethylnitrosamine induced liver injury in rat. Chem Biol Interact 295:84–9210.1016/j.cbi.2017.10.009 ↗
69. Olbert M, Gdula-Argasińska J, Nowak G, Librowski T (2017) Beneficial effect of nanoparticles over standard form of zinc oxide in enhancing the anti-inflammatory activity of ketoprofen in rats. Pharmacol Rep 69(4):679–68210.1016/j.pharep.2017.02.004 ↗
70. Torabi M, Kesmati M, Pourreza N, Najafzadeh Varzi H, Galehdari H (2018) Time dependent difference effects of MgO and ZnO nanoparticles on the serum and hippocampus Mg2+, Zn2+, Fe2+/3+ and Ca2+ levels in the stressed rats. Nanomed Res J 3(4):197–205
71. Rahdar A, Hajinezhad MR, Bilal M, Askari F, Kyzas GZ (2020) Behavioral effects of zinc oxide nanoparticles on the brain of rats. Inorg Chem Commun 119:10813110.1016/j.inoche.2020.108131 ↗
72. Ben-Slama IMI, Rihane N, Mir LE, Sakly M et al (2015) Sub-acute oral toxicity of zinc oxide nanoparticles in male rats. J Nanomed Nanotechnol 6(3):1–6
73. Isapare N, Kesmati M, Mohammadi T (2015) The effect of chronic administration of conventional and nano-sized zinc oxide on the hippocampus tissue of adult male mice. J Adv Med Biomed Res 23(101):77–87
74. Zhao J, Xu L, Zhang T, Ren G, Yang Z (2009) Influences of nanoparticle zinc oxide on acutely isolated rat hippocampal CA3 pyramidal neurons. Neurotoxicology 30(2):220–23010.1016/j.neuro.2008.12.005 ↗
75. Sawicki K, Czajka M, Matysiak-Kucharek M, Fal B, Drop B, Męczyńska-Wielgosz S et al (2019) Toxicity of metallic nanoparticles in the central nervous system. Nanotechnol Rev 8(1):175–20010.1515/ntrev-2019-0017 ↗
76. Attia H, Nounou H, Shalaby M (2018) Zinc oxide nanoparticles induced oxidative DNA damage, inflammation and apoptosis in rat’s brain after oral exposure. Toxics 6(2):2910.3390/toxics6020029 ↗
77. Yadav E, Yadav P (2021) Biofabricated zinc oxide nanoparticles impair cognitive function via modulating oxidative stress and acetylcholinesterase level in mice. Environ Toxicol 36(4):572–58510.1002/tox.23062 ↗
78. Ahlam AA, Shaniba VS, Jayasree PR, Manish Kumar PR (2021) Spondias pinnata (L.f.) Kurz leaf extract derived zinc oxide nanoparticles induce dual modes of apoptotic-necrotic death in HCT 116 and K562 cells. Biol Trace Elem Res 199(5):1778–80110.1007/s12011-020-02303-8 ↗
79. Patrón-Romero LL-MP, Loera-Castañeda V, Lares-Asseff I, Leal-Ávila MÁ, Alvelais-Palacios JA, Plasencia-López I et al (2022) Mitochondrial dysfunction induced by zinc oxide nanoparticles. Crystals 12:108910.3390/cryst12081089 ↗
80. Zahra J, Iqbal S, Zahra K, Javed Z, Shad MA, Akbar A et al (2017) Effect of variable doses of zinc oxide nanoparticles on male Albino mice behavior. Neurochem Res 42(2):439–44510.1007/s11064-016-2090-y ↗
81. Swain PS, Rao SBN, Rajendran D, Dominic G, Selvaraju S (2016) Nano zinc, an alternative to conventional zinc as animal feed supplement: a review. Anim Nutr 2(3):134–14110.1016/j.aninu.2016.06.003 ↗
82. Torabi M, Kesmati M, Pourreza N, Najafzadeh Varzi H, Galehdari H (2018) Neurobehavioral and biochemical modulation following administration of MgO and ZnO nanoparticles in the presence and absence of acute stress. Life Sci 203:72–8210.1016/j.lfs.2018.04.023 ↗
83. Liu H, Kang P, Liu Y, An Y, Hu Y, Jin X et al (2020) Zinc oxide nanoparticles synthesised from the Vernonia amygdalina shows the anti-inflammatory and antinociceptive activities in the mice model. Artif Cells Nanomed Biotechnol 48(1):1068–107810.1080/21691401.2020.1809440 ↗
84. Kesmati M, Torabi M, Ghandizadeh Dezfuli M (2014) Nanoparticles of zinc oxide reduces acute somatic pain in adult female Wistar rats. Zahedan J Res Med Sci 16:24–28
85. Kesmati M, Torabi M, Malek Shahi nia H, Teymuri Zamaneh H (2013) Effect of chronic administration of zinc supplements (ZnO and nano ZnO) with and without aerobic exercise on nociception in male rats. PhyPha 16(4):415–22
86. Rodríguez-Muñoz M, Sánchez-Blázquez P, Vicente-Sánchez A, Berrocoso E, Garzón J (2012) The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control. Neuropsychopharmacology 37(2):338–34910.1038/npp.2011.155 ↗
87. Wozniak KM, Rojas C, Wu Y, Slusher BS (2012) The role of glutamate signaling in pain processes and its regulation by GCP II inhibition. Curr Med Chem 19(9):1323–133410.2174/092986712799462630 ↗
88. Holton KF (2022) Modulation of glutamate for chronic pain management. In: Pavlovic ZM (ed) Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments. Springer International Publishing p, Cham, pp 381–40210.1007/978-3-030-87480-3_13 ↗
89. Lee K, Mills Z, Cheung P, Cheyne JE, Montgomery JM (2022) The role of zinc and NMDA receptors in autism spectrum disorders. Pharmaceuticals (Basel) 16(1):110.3390/ph16010001 ↗
90. Jalali-Yazdi F, Chowdhury S, Yoshioka C, Gouaux E (2018) Mechanisms for zinc and proton inhibition of the GluN1/GluN2A NMDA receptor. Cell 175(6):1520–32.e1510.1016/j.cell.2018.10.043 ↗
91. Mitchell JS, Hermens DF, Bennett MR, Can AT, Lagopoulos J (2023) Ketamine and zinc: treatment of anorexia nervosa via dual NMDA receptor modulation. CNS Drugs 37(2):159–18010.1007/s40263-022-00984-4 ↗
92. Hansen KB, Yi F, Perszyk RE, Furukawa H, Wollmuth LP, Gibb AJ et al (2018) Structure, function, and allosteric modulation of NMDA receptors. J Gen Physiol 150(8):1081–110510.1085/jgp.201812032 ↗
93. Chuang SH, Reddy DS (2019) Zinc reduces antiseizure activity of neurosteroids by selective blockade of extrasynaptic GABA-A receptor-mediated tonic inhibition in the hippocampus. Neuropharmacology 148:244–25610.1016/j.neuropharm.2018.11.031 ↗
94. Qian X, Zhao X, Yu L, Yin Y, Zhang XD, Wang L et al (2023) Current status of GABA receptor subtypes in analgesia. Biomed Pharmacother 168:11580010.1016/j.biopha.2023.115800 ↗
95. Kim B, Kim G, Jeon S, Cho WS, Jeon HP, Jung J (2023) Zinc oxide nanoparticles trigger autophagy-mediated cell death through activating lysosomal TRPML1 in normal kidney cells. Toxicol Rep 10:529–53610.1016/j.toxrep.2023.04.012 ↗